Aptinyx Inc reported $-19827000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -113.06M 69.96M
Acorda Therapeutics ACOR:US $ -24.52M 3.96M
Biogen BIIB:US $ 303.8M 64.4M
Cara Therapeutics CARA:US $ -27749000 5.63M
Daiichi Sankyo 4568:JP Y -27345M 59198M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Intra Cellular Therapies ITCI:US $ -72.12M 13.62M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Marinus Pharmaceuticals MRNS:US $ -19.36M 8.94M
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Novartis NOVN:VX SF 2222M 14086M
Ultragenyx Pharmaceutical RARE:US $ -152.32M 29.86M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M